Home › Funds › EMERALD MUTUAL FUND ADVISERS TRUST › TRVI

EMERALD MUTUAL FUND ADVISERS TRUST position in TRVI

TREVI THERAPEUTICS INC COM · Health Care

EMERALD MUTUAL FUND ADVISERS TRUST reported holding 1,210,965 shares of TRVI (TREVI THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$22.6M, representing 0.79% of its reported portfolio and ranking #50 among its reported holdings. EMERALD MUTUAL FUND ADVISERS TRUST has disclosed TRVI holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.21M sh
Reported value held$22.58M
Portfolio Weight0.79%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How EMERALD MUTUAL FUND ADVISERS TRUST's TRVI position evolved

EMERALD MUTUAL FUND ADVISERS TRUST first disclosed a stake in TRVI in Q4 2025 at 1,272,373 shares (US$15.9M). The position peaked in Q2 2026 at 1,210,965 shares, worth US$22.6M. Across 3 filings, EMERALD MUTUAL FUND ADVISERS TRUST increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,210,965 shares valued at US$22.6M — a reduction of -51,527 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.27M $15.93M New
Q1 2026 1.26M $15.06M Reduce
Q2 2026 1.21M $22.58M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRVI and 13F data

TRVI (TREVI THERAPEUTICS INC COM) is a Health Care company. 64 other funds we track also report a position in TRVI — the largest reported positions include NEA Management Company, LLC (US$246.6M), Frazier Life Sciences Management, L.P. (US$185.4M), Vivo Capital, LLC (US$95.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRVI

All TRVI fund holders →

FAQ

How long has EMERALD MUTUAL FUND ADVISERS TRUST held TRVI?

EMERALD MUTUAL FUND ADVISERS TRUST has disclosed TRVI holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is EMERALD MUTUAL FUND ADVISERS TRUST's current position in TRVI?

As of Q2 2026, EMERALD MUTUAL FUND ADVISERS TRUST holds 1.21M shares of TRVI (TREVI THERAPEUTICS INC COM), valued at $22.58M, representing 0.79% of its reported portfolio and ranking #50.

Has EMERALD MUTUAL FUND ADVISERS TRUST been buying or selling TRVI?

In the latest 13F filing (Q2 2026), EMERALD MUTUAL FUND ADVISERS TRUST reduced its position in TRVI. The position peaked in Q2 2026 at 1.21M shares.

Which other funds hold TRVI?

Other major institutional holders of TRVI include NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.